" I found the Synaptic Pain Management System on par with the other modalities and a definite benefit in returning my atheletes to the boats with minimal time lost".
Dick F. Dent A.T.C. Head Athletic Trainer The Women’s Team
“With many of our painful muscle and joint injuries, the Synaptic delivers results superior to conventional electrical stimulation modalities . . . In some cases of acute and chronic pain the relief is both dramatic and long lasting.
J. Lindsay McLean, ATC, PT Head Athletic Trainer for the San Francisco 49ers
"Our best successes have come using it with inflammatory conditions such as tendinitis and bursitis.”
Jennifer A. Stone, Manager, Clinical services – Internal Programs Sports Medicine Division
The Synaptic Corporation markets The Synaptic® Pain Management System under the current FDA guidelines. These guidelines stipulate that the Synaptic® Pain Management System is cleared for the treatment of acute and chronic pain conditions.
Â
FDA: The Synaptic Pain Control System is clinically indicated for symptomatic relief and management of chronic and post-traumatic acute pain. The FDA authorization to market was granted June 20, 1997. Federal Law restricts this medical device to sale by or on the order of a licensed medical practitioner.
